Beam Therapeutics, Inc. (BEAM)
29.61
-2.68
(-8.30%)
USD |
NASDAQ |
Feb 25, 16:00
29.75
+0.14
(+0.47%)
Pre-Market: 08:36
Beam Therapeutics Gross Profit (Quarterly) : 108.44M for Dec. 31, 2025
Gross Profit (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 8.846M |
| Twist Bioscience Corp. | 53.97M |
| Pacific Biosciences of California, Inc. | 16.75M |
| Stryker Corp. | 4.504B |
| Zimmer Biomet Holdings, Inc. | 1.262B |